Bicara Therapeutics Inc. ... (BCAX)
NASDAQ: BCAX
· Real-Time Price · USD
11.23
-0.18 (-1.58%)
At close: Aug 15, 2025, 10:04 AM
Bicara Therapeutics Common Stock Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 19K | 19K | 15K | 15K | 13K | 13K | n/a | 2K | n/a | n/a |
Gross Profit | -19K | -19K | -15K | -15K | -13K | -13K | n/a | -2K | n/a | n/a |
Operating Income | -32.02M | -41.79M | -26.64M | -20.63M | -17.56M | -17.56M | -13.69M | -9.53M | -8.34M | -8.34M |
Interest Income | 4.68M | 5.01M | 5.87M | 3.15M | 2.7M | 2.87M | 1.3M | 13K | n/a | n/a |
Pretax Income | -27.34M | -36.77M | -20.77M | -17.48M | -14.78M | -14.78M | -12.44M | -22.84M | -8.35M | -8.35M |
Net Income | -27.39M | -36.85M | -20.96M | -17.48M | -14.78M | -14.78M | -12.44M | -22.84M | -8.35M | -8.35M |
Selling & General & Admin | 7.22M | 7.46M | 6.75M | 4.76M | 3.63M | 3.63M | 3.13M | 2.59M | 1.78M | 1.78M |
Research & Development | 2.93M | 6.58M | 19.88M | 15.86M | 13.94M | 13.94M | 10.56M | 6.94M | 6.56M | 6.56M |
Other Expenses | 21.87M | 27.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 32.02M | 41.79M | 26.64M | 20.63M | 17.56M | 17.56M | 13.69M | 9.53M | 8.34M | 8.34M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.02M | 41.79M | 26.64M | 20.63M | 17.56M | 17.56M | 13.69M | 9.53M | 8.34M | 8.34M |
Income Tax Expense | 52K | -72K | 186K | n/a | 500.00 | 500.00 | 5K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 54.54M | 54.46M | 54.44M | 54.41M | 54.18M | 54.18M | 53.09M | 54.41M | 54.6M | 54.6M |
Shares Outstanding (Diluted) | 54.54M | 54.46M | 54.44M | 54.41M | 54.18M | 54.18M | 53.09M | 54.41M | 54.62M | 54.62M |
EPS (Basic) | -0.5 | -0.68 | -0.38 | -0.32 | -0.27 | -0.27 | -0.23 | -0.42 | -0.15 | -0.15 |
EPS (Diluted) | -0.5 | -0.68 | -0.38 | -0.32 | -0.27 | -0.27 | -0.23 | -0.42 | -0.15 | -0.15 |
EBITDA | -32.02M | -41.79M | -26.62M | -20.61M | -17.55M | -17.55M | -25.76M | -9.53M | -8.33M | -8.33M |
EBIT | -27.34M | -36.77M | -26.64M | -20.63M | -17.56M | -17.56M | -25.78M | -9.53M | -8.34M | -8.34M |
Depreciation & Amortization | n/a | 19K | 15K | 15K | 13K | 13K | 14K | 2K | 1.5K | 1.5K |